Invitation to presentation of Bactiguard’s interim report for the second quarter on August 15
Bactiguard Holding AB publishes the interim report for the second quarter 2014 on August 15 at 08:00 CET.
In connection with this, a telephone conference for analysts and media will be held at 10:00 CET on August 15. CEO Johan Rugfelt and CFO Fredrik Järrsten will present the interim report and answer questions.
The report will be available at www.bactiguard.com from 08:00 CET the same day.
To participate in the conference, please dial +46 851999354
For further information, please contact:
Cecilia Edström, Director of Communications
Mobile: +46 722 262 328; e-mail: email@example.com
For questions related to participation in the conference call, please contact:
Tfn: +46 8 440 58 69; e-mail: firstname.lastname@example.org
Bactiguard is a Swedish medtech company with a mission of preventing healthcare associated infections, reducing the use of antibiotics and saving lives by developing and supplying infection prevention solutions to the healthcare industry. The company’s patented coating prevents healthcare associated infections by reducing bacterial adhesion and growth on medical devices. Bactiguard®-coated urinary catheters are market leading in the US and Japan, and in recent years the company has developed its own product portfolio of coated catheters for the urinary and respiratory tract and the blood stream. Bactiguard is currently in a strong expansion phase, focused on new markets in the EU, Middle East, Asia and South America. The company reported sales of approximately SEK 130 million in 2013, has 60 employees, headquarters in Stockholm and production facilities in Markaryd and Malaysia. More information is available at www.bactiguard.se